Abstract:Epidemiological and experimental studies suggest that a disease-aggravating neuroinflammatory process is present at preclinical stages of Alzheimer's disease. Given that individuals with Down syndrome are at increased genetic risk of Alzheimer's disease and therefore develop the spectrum of Alzheimer's neuropathology in a uniform manner, they constitute an important population to study the evolution of neuroinflammation across the Alzheimer's continuum. Therefore, in this cross-sectional study, we characterized the brain inflammatory profile across the lifespan of individuals with Down syndrome. Microglial morphology and inflammatory cytokine expression were analysed by immunohistochemistry and electrochemiluminescent-based immunoassays in the frontal cortex from foetuses to adults with Down syndrome and control subjects (16 gestational weeks to 64 years), totalling 127 cases. Cytokine expression in mixed foetal primary cultures and hippocampus of adults with Down syndrome, as well as the effects of sex on cytokine expression were also analysed. A higher microglial soma size-to-process length ratio was observed in the frontal cortex of children and young adults with Down syndrome before the development of full-blown Alzheimer's pathology. Moreover, young adults with Down syndrome also displayed increased numbers of rod-like microglia. Increased levels of interleukin-8 and interleukin-10 were observed in children with Down syndrome (1-10 years; Down syndrome n = 5, controls n = 10) and higher levels of interleukin-1β, interleukin-1α, interleukin-6, interleukin-8, interleukin-10, interleukin-15, eotaxin-3, interferon gamma-induced protein 10, macrophage-derived chemokine, and macrophage inflammatory protein-beta, were found in young adults with Down syndrome compared to euploid cases (13-25 years, Down syndrome n = 6, controls n = 24). Increased cytokine expression was also found in the conditioned media of mixed cortical primary cultures from second trimester foetuses with Down syndrome (Down syndrome n = 7, controls n = 7). Older adults with Down syndrome (39-68 years, Down syndrome n = 22, controls n = 16) displayed reduced levels of interleukin-10, interleukin-12p40, interferon-gamma and tumour necrosis factor-alpha. Microglia displayed larger somas and shorter processes. Moreover, an increase in dystrophic microglia and rod-like microglia aligning to neurons harbouring tau pathology were also observed. Sex stratification analyses revealed that females with Down syndrome had increased interleukin-6 and interleukin-8 levels compared to males with Down syndrome. Finally, multivariate projection methods identified specific cytokine patterns among individuals with Down syndrome. Our findings indicate the presence of an early and evolving neuroinflammatory phenotype across the lifespan in Down syndrome, a knowledge that is relevant for the discovery of stage-specific targets and for the design of possible anti-inflammatory trials against Alzheimer's disease in this population.

The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome

Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children

Increased Endocytic Activity in Monocyte-Derived Dendritic Cells in Patients with Psoriasis Vulgaris

Aberrations in Circulating Inflammatory Cytokine Levels in Patients with Down Syndrome: a Meta-Analysis

Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome

Immune Dysregulation in Children With Down Syndrome

Genome-wide expression analysis in Down syndrome: insight into immunodeficiency

Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells

Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome

Expression profile of inflammasome genes in individuals with Down syndrome

Immune and TRG repertoire signature of the thymus in Down syndrome patients

Down Syndrome in Children: A Primary Immunodeficiency with Immune Dysregulation

Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome

Altered peripheral blood leukocyte subpopulations, function, and gene expression in children with Down Syndrome: Implications for respiratory tract infection

Evolution of neuroinflammation across the lifespan of individuals with Down syndrome

Single‐cell landscape analysis reveals systematic senescence in mammalian Down syndrome

Mirna-155 Upregulation and Complement Factor H Deficits in Down’s Syndrome

IgG1 glycosylation highlights premature aging in Down syndrome

Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics

Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes

Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome